Position in LLY
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$169,325,058
-$20,206,599 QoQ
Shares Held
184,095
+4.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $721,115,080 across 17 Drug Manufacturers - General names. LLY ranks #2 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
888,033 | $217,070,786 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
184,095 | $169,325,058 | |
| 3 | ABBV |
AbbVie Inc.
|
632,140 | $137,484,128 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
392,435 | $54,693,665 | |
| 5 | MRK |
Merck & Co., Inc.
|
341,876 | $41,124,264 | |
| 6 | AMGN |
Amgen Inc
|
95,939 | $33,756,137 | |
| 7 | PFE |
Pfizer Inc
|
712,319 | $20,001,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
226,056 | $13,710,296 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $169,325,058 | 184,095 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $189,531,657 | 176,361 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $96,519,500 | 126,500 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $98,757,876 | 126,689 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $100,698,250 | 121,924 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $93,216,684 | 120,747 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $108,157,327 | 122,082 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $111,512,938 | 123,167 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $83,111,800 | 106,833 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $58,177,164 | 99,803 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $39,475,832 | 73,494 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,633,169 | 67,451 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,481,646 | 65,464 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $25,119,671 | 68,663 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $19,777,702 | 61,165 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,257,241 | 62,478 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $15,192,501 | 53,052 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,335,349 | 48,278 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $8,738,772 | 37,822 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $7,350,837 | 32,027 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $5,872,686 | 31,435 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $6,141,386 | 36,374 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $21,179,885 | 143,088 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $6,229,481 | 37,943 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $5,004,185 | 36,074 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||